University of California San Francisco
Give to UCSF
UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique genetic signal. This could revolutionize ICU care and prevent thousands of patients from receiving unnecessary antibiotics.
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without long-term antiretroviral therapy (ART). In a small study, 7 of 10 participants maintained low HIV levels after stopping medications, reprogramming their immune systems.
With the CDC, FDA, and states providing different guidance on COVID-19 vaccines, UCSF physicians weigh in about who should get the shot, when, and what insurance covers.
A TED Talk-style presentation on the effects of tangled DNA strands took first place at this year's Postdoc Slam competition, which is held in celebration of National Postdoc Appreciation Week.
A UCSF-led study finds a new class of insecticide that can be disseminated on material the size of a sheet of paper that offers protection for up to a year against mosquitoes that spread malaria, as well as dengue, West Nile, yellow fever, and Zika.
Two new Pew Latin American fellows, Beatriz De Moraes, PhD, and Lilian Gomes de Oliveira, PhD, will each receive a $30,000 annual stipend for two years to support their work at the crossroads of immunology and neuroscience.
A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.
UC San Francisco’s Paul Farmer African Initiative for Research (PFAIR) supports African scientists in infectious disease research via mentorship, international collaboration, and sustainable funding.
Many experts believe that social isolation is a risk factor for Alzheimer’s disease, but a new study found that the disease may make them more sociable rather than less — at least in the early stages.
An off-the-shelf drug developed for smallpox, a cousin of mpox, proved safe for mpox patients but ineffective at curing the disease. But the clinical trial itself, launched rapidly as cases spread in 2022, could be a model for similar current and future epidemics.
Neurosurgeon Edward Chang, MD, developmental geneticist Thomas Kornberg, PhD, and virologist Raul Andino-Pavlovsky, PhD, have been elected to the National Academy of Sciences (NAS), one of the highest honors in American science.
A team at UCSF and Gladstone Institutes developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could cause future pandemics.
CT scans may account for 5% of all cancers annually, according to a new study that cautions against overusing and overdosing CTs.
UCSF received $815 million in awards from the National Institutes of Health (NIH) last year for research that will improve the lives of patients in the U.S. and around the world.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.
Tuberculosis has stalked humanity for as nearly as long as we've been on earth. In this article, we take a look at how UCSF is leading the fight against the leading infectious disease killer.
A Q&A w/Alison Cohen, PhD, MPH, who is among the estimated 5% of the population with Long COVID. She talks through the implications of Long COVID, and how she applies her scientific and personal experience to research this debilitating condition.
UCSF scientists are taking the first steps toward creating a new type of antibiotic that uses an unusual virus to defeat antibiotic-resistant bacteria.
Rates of advanced prostate cancer in California rose significantly in the decade since doctors stopped routinely screening all men. A UCSF study reinforces the need for screening that can identify potentially fatal tumors without raising false alarms about ones that pose little threat.
Several cases of the bird flu in humans have been reported in California's Central Valley in 2024. This Q&A explores how the virus spreads, how to prevent infection and whether this is something to be we need to actively protect against.
